Polaris™ Ultra M0061921440Recalls & reported problems
Boston Scientific Corporation · Ureteral Stent · Class 2 · Implant
All models of Polaris Ultra (40)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08714729124580), received between Jun 3, 2021 and Oct 14, 2021 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Detachment of Device or Device Component1
- Difficult to Advance1
- Material Split, Cut or Torn1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
- Urinary Tract Infection1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionOct 14, 2021Detachment of Device or Device Component; Difficult to Advance; Material Split, Cut or Torn; Detachment of Device or Device Component; Difficult to Advance; Material Split, Cut or Torn
NOTE: THIS REPORT PERTAINS TO A SENSOR WIRE AND POLARIS ULTRA STENT DURING THE SAME PROCEDURE. REFER TO MANUFACTURER REPORT# 3005099803-2021-05215 FOR THE OTHER ASSOCIATED DEVICE INFORMATION. IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A POLARIS ULTRA URETERAL STENT AND A SENSOR WIRE WAS USED DURING URETEROSCOPY PROCEDURE IN THE KIDNEY PERFORMED ON (B)(6) 2021. DURING PROCEDURE CLOSURE, THE TECHNICIAN ENCOUNTERED RESISTANCE WHEN ATTEMPTING TO PULL THE GUIDEWIRE OUT AND PHYSICIAN INSTRUCTED HER TO CONTINUE. THE GUIDEWIRE TIP TORE THE ENTIRE LENGTH OF THE STENT AND THE COIL WAS DETACHED. UPON REMOVAL, IT WAS NOTED THE GUIDEWIRE COREWIRE TIP WAS BROKEN INSIDE THE PATIENT WHEN WIRE WAS BEING PULLED OUT. THE PROCEDURE WAS COMPLETED WITH A NEW POLARIS ULTRA STENT AND SENSOR WIRE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12636661 ↗InjuryJun 3, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A POLARIS ULTRA STENT WAS IMPLANTED DURING A STENT PLACEMENT PROCEDURE FOR STONE PLACEMENT MANAGEMENT AND LASER LITHOTRIPSY IN THE LEFT DISTAL URETER ON (B)(6) 2021 AS PART OF THE (B)(6) CLINICAL STUDY. ON (B)(6) 2021, A PLANNED STENT REMOVAL WAS PERFORMED. THE IMPLANTED STENT WAS SUCCESSFULLY REMOVED WITH NO DIFFICULTY VIA A CYTO/GRASPER IN THE OPERATING ROOM. ORAL PAIN CONTROL WAS GIVEN TO THE PATIENT. THERE WAS NO NEW DEVICE IMPLANTED. THE PATIENT'S CONDITION FOLLOWING THE REMOVAL PROCEDURE IS REPORTED TO BE STABLE. ON (B)(6) 2021, THE PATIENT WAS HOSPITALIZED DUE TO A URINARY TRACT INFECTION. THE PATIENT WAS GIVEN ANTIBIOTICS AND HOSPITALIZED OVERNIGHT DUE TO THE URINARY TRACT INFECTION. THE EVENT WAS CONSIDERED TO BE RESOLVED AS OF (B)(6) 2021 AND WAS DISCHARGED FROM THE HOSPITAL. IN THE PHYSICIAN'S ASSESSMENT, THE RELATIONSHIP BETWEEN THE PROCEDURE AND THE URINARY TRACT INFECTION IS UNLIKELY RELATED AND THE RELATIONSHIP BETWEEN THE DEVICE AND THE URINARY TRACT INFECTION IS POSSIBLE.
Patient problems: Urinary Tract Infection
MAUDE report 11930101 ↗
Other STENT, URETERAL devices
- Bard® InLay Optima® Ureteral Stent 788426C. R. Bard, Inc. · STENT, URETERAL1 recall100 reports
- Bard® InLay Optima® Ureteral Stent 788626C. R. Bard, Inc. · STENT, URETERAL122 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777626C. R. Bard, Inc. · STENT, URETERAL118 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777426C. R. Bard, Inc. · STENT, URETERAL108 reports
- Bard® InLay® Ureteral Stent 778626C. R. Bard, Inc. · STENT, URETERAL100 reports
- Percuflex™ Plus M0061752530Boston Scientific Corporation · STENT, URETERAL1 death99 reports
- Contour VL™ M0061801560Boston Scientific Corporation · STENT, URETERAL1 recall45 reports
- Polaris™ Ultra M0061921330Boston Scientific Corporation · STENT, URETERAL71 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page